Gilat Secures $11M in U.S. Defense Orders, But Core Margin and Deal Risks Persist

What happened

Gilat received $11 million in orders from the U.S. Department of War, adding to its defense backlog and underscoring continued demand for its field services and ruggedized terminals. However, this award, while positive, is modest relative to Gilat's $500M+ revenue guidance and does little to alleviate the pressing issues of Commercial segment margin compression and the pending Comtech acquisition. The company's Commercial gross margin slumped to 27% in FY2025 due to Stellar Blu Solutions' early production inefficiencies, and the Comtech deal—expected to close by end-2026—faces HSR and CFIUS clearance risks. Management has yet to demonstrate that Sidewinder ESA orders will convert into cash-generative margins, and recent insider selling (CEO and CLO liquidating entire holdings) raises questions about internal confidence. Until these fundamental uncertainties are resolved, the stock remains a speculative hold rather than a deep-value opportunity.

Implication

Sustained defense orders could gradually de-risk the thesis, but investors should focus on Commercial margin improvement above 30% and timely Comtech closing. Full-position sizing only after these two catalysts materialize.

Thesis delta

The news reinforces existing defense momentum but does not alter the core thesis: Gilat's valuation depends on proving commercial unit economics and executing the Comtech acquisition. The story remains 'show-me' with no change in the WAIT rating.